drugset / Trial / NCT03724903

Ductal Lavage Versus Corticosteroids Therapy for Idiopathic Granulomatous Mastitis

NCT03724903

RandomizedParallel-groupOpen-labelTreatment

Summary

A single-arm, proof-of-concept trial has shown the safety and efficacy of ductal lavage as a treatment for idiopathic granulomatous mastitis patients (Manuscript accepted in Journal of Surgical Research 2018). In this multicenter, randomized, open-labeled, non-inferior trial, the investigators are going to enroll eligible granulomatous mastitis patients and randomized them into ductal lavage versus. corticosteroids therapy group. The primary endpoint of this study is the complete clinical response rate at 1 year after the enrollment. The aim of this study is to provide evidence for the management of idiopathic granulomatous mastitis patients .

Timeline

Start
2019-04-01
Primary completion
2023-04-21
Completion
2023-04-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified Oral
Comparator Prednisone Other / unclassified 20 mg Oral